SEC Filing Details

Document Details

Form
4
Filing Date
Mar 21, 2023
Document Date
Mar 18, 2023
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Cumberland Pharmaceuticals, Inc.
Issuer
CUMBERLAND PHARMACEUTICALS INC